- Home
- QUIK vs ADAG Comparison
QUIK vs ADAG Comparison
Compare QUIK & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUIK
- ADAG
- Stock Information
- Founded
- QUIK 1988
- ADAG 2011
- Country
- QUIK United States
- ADAG China
- Employees
- QUIK N/A
- ADAG N/A
- Industry
- QUIK Semiconductors
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- QUIK Technology
- ADAG Health Care
- Exchange
- QUIK Nasdaq
- ADAG Nasdaq
- Market Cap
- QUIK 87.3M
- ADAG 81.9M
- IPO Year
- QUIK 1997
- ADAG 2021
- Fundamental
- Price
- QUIK $5.90
- ADAG $1.61
- Analyst Decision
- QUIK Strong Buy
- ADAG Strong Buy
- Analyst Count
- QUIK 3
- ADAG 1
- Target Price
- QUIK $11.53
- ADAG $8.00
- AVG Volume (30 Days)
- QUIK 94.9K
- ADAG 13.0K
- Earning Date
- QUIK 05-13-2025
- ADAG 03-24-2025
- Dividend Yield
- QUIK N/A
- ADAG N/A
- EPS Growth
- QUIK N/A
- ADAG N/A
- EPS
- QUIK N/A
- ADAG N/A
- Revenue
- QUIK $20,112,000.00
- ADAG $103,204.00
- Revenue This Year
- QUIK $22.56
- ADAG $6,488.89
- Revenue Next Year
- QUIK $21.66
- ADAG $57.50
- P/E Ratio
- QUIK N/A
- ADAG N/A
- Revenue Growth
- QUIK N/A
- ADAG N/A
- 52 Week Low
- QUIK $4.26
- ADAG $1.33
- 52 Week High
- QUIK $16.13
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- QUIK 59.62
- ADAG 52.98
- Support Level
- QUIK $5.31
- ADAG $1.51
- Resistance Level
- QUIK $5.98
- ADAG $1.74
- Average True Range (ATR)
- QUIK 0.35
- ADAG 0.10
- MACD
- QUIK 0.12
- ADAG 0.03
- Stochastic Oscillator
- QUIK 83.53
- ADAG 65.79
About QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.